Effects of evolocumab therapy and low LDL‐C levels on vitamin E and steroid hormones in Chinese and global patients with type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of evolocumab therapy and low LDL‐C levels on vitamin E and steroid hormones in Chinese and global patients with type 2 diabetes

Published:2020-03-06 Issue:2 Volume:3 Page:
ISSN:2398-9238
Container-title:Endocrinology, Diabetes & Metabolism
language:en
Short-container-title:Endocrinol Diab Metab

Author:

Blom Dirk J.¹^ORCID,Chen Jiyan²,Yuan Zuyi³,Borges Joao L. C.⁴,Monsalvo Maria L.⁵,Wang Nan⁵,Hamer Andrew W.⁵,Ge Junbo⁶

Affiliation:

1. University of Cape Town Cape Town South Africa

2. Guangdong Cardiovascular Institute Guangdong General Hospital Guangzhou China

3. First Affiliated Hospital of Xi’an Jiaotong University Xi’an China

4. Universidade Catolica de Brasilia Brasilia Brazil

5. Amgen Inc. Thousand Oaks CA USA

6. Zhongshan Hospital Fudan University Shanghai China

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.123

Reference35 articles.

1. Genetics of Dyslipidemia and Ischemic Heart Disease

2. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

3. Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial

4. Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial

5. Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Inclisiran, Alirocumab, Evolocumab, and Evinacumab in Lipid-Lowering: A Network Meta-Analysis;2024-04-17

2. Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study;Cancers;2024-04-04

3. The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date;Medicina;2024-01-30

4. A review on the efficacy and safety of lipid-lowering drugs in neurodegenerative disease;Reviews in the Neurosciences;2023-04-10

5. Genetics, Safety, Cost-Effectiveness, and Accessibility of Injectable Lipid-Lowering Agents: A Narrative Review;Journal of Lipids;2023-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3